http://www.legislation.gov.uk/uksi/2012/1916/regulation/307/2014-03-31
The Human Medicines Regulations 2012
text
text/xml
en
Statute Law Database
MEDICINES
2024-07-10
Expert Participation
2014-03-31
These Regulations consolidate the law of the United Kingdom concerning medicinal products for human use (“products”) in respect of the topics described below.
The Human Medicines Regulations 2012
reg. 51(9)
The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019
Sch. 1
para. 5
reg. 1
The Human Medicines Regulations 2012
reg. 53(2)(a)
The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019
Sch. 1
para. 6(2)
reg. 1
The Human Medicines Regulations 2012
Sch. 33A
para. 57(2)
The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019
Sch. 1
para. 10(3)(a)
reg. 1
The Human Medicines Regulations 2012
Sch. 33A
para. 57(3)
The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019
Sch. 1
para. 10(3)(b)
reg. 1
The Human Medicines Regulations 2012
Sch. 33A
para. 57A
The Human Medicines and Medical Devices (Amendment etc.) (EU Exit) Regulations 2019
Sch. 1
para. 10(4)
reg. 1
The Human Medicines Regulations 2012
reg. 52(1)(a)(i)(ii) and words
The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019
reg. 57(2)
reg. 1
The Human Medicines Regulations 2012
reg. 53(2)-(2C)
The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019
reg. 58(3)
reg. 1
The Human Medicines Regulations 2012
Sch. 11
para. 1(1)(d)-(f)
The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019
reg. 63(2)(a)(ii)
reg. 1
The Human Medicines Regulations 2012
reg. 3(12)(d)
(ia)
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 4(a)
reg. 1(1)
The Human Medicines Regulations 2012
reg. 4(4)(d)
(ia)
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 5
reg. 1(1)
The Human Medicines Regulations 2012
reg. 43(7)(b)(ii)(bb)
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 18(b)
reg. 1(1)
The Human Medicines Regulations 2012
reg. 49(1ZA)-(1ZD)
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 26(a)
reg. 1(1)
The Human Medicines Regulations 2012
reg. 49(3ZA)
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 26(d)
reg. 1(1)
The Human Medicines Regulations 2012
reg. 55(1)(b)(iii)(bb)
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 43(a)(ii)
reg. 1(1)
The Human Medicines Regulations 2012
reg. 60A(10A)
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 49(e)
reg. 1(1)
The Human Medicines Regulations 2012
reg. 68(11H)-(A12)
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 56(b)
reg. 1(1)
The Human Medicines Regulations 2012
reg. 257(9)
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 110(c)
reg. 1(2)
reg. 1(1)
The Human Medicines Regulations 2012
reg. 257AA
257AB
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 111
reg. 1(2)
reg. 1(1)
The Human Medicines Regulations 2012
reg. 327(1)(c)
(va)
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 128(a)
reg. 1(1)
The Human Medicines Regulations 2012
reg. 346(2)(c)
(iia)
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 132(b)
reg. 1(1)
The Human Medicines Regulations 2012
reg. 346(2)(c)
(iiia)
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 132(b)
reg. 1(1)
The Human Medicines Regulations 2012
reg. 346(2)(c)
(iva)
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 132(b)
reg. 1(1)
The Human Medicines Regulations 2012
reg. 346(2)(c)
(xviia)
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 132(b)
reg. 1(1)
The Human Medicines Regulations 2012
reg. 346(2)(c)
(xxviiij)
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 132(b)
reg. 1(1)
The Human Medicines Regulations 2012
reg. 347B
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 133
reg. 1(1)
The Human Medicines Regulations 2012
Sch. 24
para. 18B
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 142(e)
reg. 1(1)
The Human Medicines Regulations 2012
Sch. 24 Pt. 1
para. 23
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 142(f)
reg. 1(1)
The Human Medicines Regulations 2012
Sch. 33B
The Human Medicines (Amendments relating to the Windsor Framework) Regulations 2024
reg. 146
reg. 1(1)
The Human Medicines Regulations 2012
reg. 173(e)
The Ionising Radiation (Medical Exposure) Regulations 2017
Sch. 4
para. 2(2)(b)
reg. 1
The Human Medicines Regulations 2012
reg. 240(2A)
The Ionising Radiation (Medical Exposure) Regulations 2017
Sch. 4
para. 2(3)(c)
reg. 1
The Human Medicines Regulations 2012
reg. 240(6A)
The Ionising Radiation (Medical Exposure) Regulations 2017
Sch. 4
para. 2(3)(g)
reg. 1
PART 14Advertising
CHAPTER 3Monitoring of Advertising
Scrutiny by Ministers
Corrective statement307
1
This regulation applies if the new notice—
a
maintains the application of a requirement imposed under regulation 305(4) to cease to publish the advertisement that is the subject of the notice; or
b
imposes a requirement to cease to publish that advertisement.
2
The new notice may require the person to whom it is given to publish—
a
the Ministers' reasons for making the determination that the advertisement was incompatible with the prohibitions imposed by Chapter 2, either in full or in part; and
b
a corrective statement concerning the advertisement.
3
A requirement imposed under paragraph (2)—
a
must specify the time within which publication must take place; and
b
may specify the form of publication.